Broker Roundup: Seymour tips Debts.co.uk

Seymour Pierce initiates coverage of Debts.co.uk with a buy rating and 260p target price.

Among other recommendations:

* Credit Suisse had a neutral stance for Northern Rock, raising target to £12.30 from £10.25, reiterates its neutral stance on Kingfisher and has an outperform rating for Carphone Warehouse

* Deutsche Bank reiterates its hold stance on GlaxoSmithKline and has a buy rating for BHP Billiton
The broker has a hold stance on CSR, reducing target to £12.40 from £13.60 and a buy rating and £13 target for Northern Rock

* Goldman Sachs has a neutral stance on Northern Rock, raising target to £11.67 and has a buy rating for Reuters
The broker has upgraded its rating for Colt Telecom to neutral from sell and reiterates its neutral stance on Centrica.

* Merrill Lynch has buy ratings for Northern Rock, GlaxoSmithKline and Wolseley and neutral stances on Reuters and Alliance & Leicester
The broker reiterates its sell rating for BT Group, has a buy rating and 375p target for Carphone Warehouse, a neutral stance on Centrica, a buy rating and 270p target for Kingfisher, a buy rating and £14 target for Liberty International, neutral stances on Rathbone Bros and Reed Elsevier, a buy rating and 500p target for Rolls-Royce, a neutral stance on Royal Dutch Shell and a buy rating for Shanks Group

* JP Morgan has an overweight rating for Reuters, reiterates its neutral stance on BT Group, advising taking profits, and a neutral stance on Northern Rock

* Morgan Stanley reiterates its overweight rating for SABMiller, has an underweight rating for Scottish & Newcastle and an overweight rating for GlaxoSmithKline

* UBS has a buy rating for BSkyB, neutral stances for GlaxoSmithKline and Reuters and has Xstrata and Lonmin has its top picks in the mining sectors
The broker reiterates its buy rating and 280p target for Kingfisher, has a buy rating for BAT, a buy rating and 160p target for Legal & General, a buy rating and 410p target for Carphone Warehouse and a buy rating and 300p target for Aggreko

* Lehman Bros has downgraded its rating for CSR to underweight from overweight cutting target to 12 from £15.50, has an overweight rating and 585p target for Reuters, an overweight rating and £17.70 target for GlaxoSmithKline, an equal-weight rating for Great Portland Estates, raising target to 559p from 514p and retains a positive stance on the oil sector